Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
Teva sees higher margins, lower debt from restructuring | Financial Times
Israel's Teva gives upbeat outlook as restructuring proceeds
Teva Abandons Search to Make Covid-19 Vaccine for Partners - Bloomberg
/cloudfront-us-east-1.images.arcpublishing.com/gray/5ORNVHIZ6FHUHL74IGLVZ6RU4Q.jpg "New York jury holds drug firm Teva liable in opioid crisis")
New York jury holds drug firm Teva liable in opioid crisis
Teva Pharmaceuticals - Wikiwand
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
US states sue Teva for price-fixing in 'multi-billion dollar fraud' | The Times of Israel
TEVA: Can Teva Pharmaceutical Stock Continue to Rebound in 2021?
Suffering from missteps, drugmaker Teva struggles to heal own ills | The Times of Israel
Teva Pharm expects U.S. opioid case settlements to cost $2.6 bln | Reuters
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Faces Rocky Path to Recovery After Debt | Fortune
Here's Why Teva Pharma Stock Is Soaring Today
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Buy Teva Pharmaceuticals amid positive news, Bernstein says
